Dale Schaar

Author PubWeight™ 5.01^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndrome.	Cancer	2011	0.95
2	Administration of a phorbol ester to patients with hematological malignancies: preliminary results from a phase I clinical trial of 12-O-tetradecanoylphorbol-13-acetate.	Clin Cancer Res	2002	0.87
3	Sequential topoisomerase targeting and analysis of mechanisms of resistance to topotecan in patients with acute myelogenous leukemia.	Anticancer Drugs	2008	0.82
4	Nuclear factor-kappaB modulation in patients undergoing induction chemotherapy for acute myelogenous leukemia.	Clin Cancer Res	2008	0.81
5	Antineoplastic effects of partially HLA-matched irradiated blood mononuclear cells in patients with renal cell carcinoma.	J Clin Oncol	2003	0.80
6	A pilot study of allogeneic cellular therapy for patients with advanced hematologic malignancies.	Leuk Res	2008	0.76
7	A call to action: Cancer in adolescents and young adults: An unrecognized healthcare disparity.	J Pediatr Hematol Oncol	2006	0.76